Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3995
Source ID: NCT00502710
Associated Drug: Placebo
Title: A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus Type 2
Interventions: DRUG: Placebo|DRUG: RO4876904
Outcome Measures: Primary: Absolute change in hemoglobin A1c (HbA1c), Week 12 | Secondary: Absolute change in fasting plasma glucose (FPG), HbA1c response rate, absolute/relative change in insulin sensitivity, beta cell function, lipid profile., Week 12|Adverse events (AEs), vital signs, laboratory parameters., Throughout study
Sponsor/Collaborators: Sponsor: Hoffmann-La Roche
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 289
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2007-07
Completion Date: 2008-04
Results First Posted:
Last Update Posted: 2016-08-05
Locations: Hot Springs, Arkansas, 71913, United States|Concord, California, 94520, United States|Los Angeles, California, 90057, United States|Chicago, Illinois, 60607, United States|Avon, Indiana, 46123, United States|Indianapolis, Indiana, 46260, United States|Oxon Hill, Maryland, 20745, United States|Troy, Michigan, 48098, United States|Omaha, Nebraska, 68154, United States|Binghamton, New York, 13901, United States|Charlotte, North Carolina, 28211, United States|Beaver, Pennsylvania, 15009, United States|Adelaide, 5000, Australia|Canberra, 2605, Australia|St. Leonards, 2065, Australia|Sao Paulo, 01244-030, Brazil|Sao Paulo, 04022-001, Brazil|Guatemala City, 01015, Guatemala|Hong Kong, Hong Kong|Aguascalientes, 20230, Mexico|Chihuahua, 31238, Mexico|Guadalajara, 44650, Mexico|Guadalajara, 45200, Mexico|Mexico City, 11650, Mexico|Pachuca, 42086, Mexico|Tampico, 89109, Mexico|Moscow, 109263, Russian Federation|Moscow, 117036, Russian Federation|Moscow, 121069, Russian Federation|Moscow, 125315, Russian Federation|Moscow, 129110, Russian Federation|Saratov, 410038, Russian Federation|St Petersburg, 195112, Russian Federation|St Petersburg, 195213, Russian Federation|St Petersburg, 197089, Russian Federation|St Petersburg, 197198, Russian Federation|Yaroslavl, 150010, Russian Federation|Yaroslavl, 150062, Russian Federation|Alzira, 46600, Spain|Bacarot Alicant, 03114, Spain|Badalona, Spain|Barcelona, 08022, Spain|Ferrol, 15405, Spain|Bath, BA1 2SR, United Kingdom|Frome, BA11 1EZ, United Kingdom|Glasgow, G45 9AW, United Kingdom|Liverpool, L9 7AL, United Kingdom|Motherwell, ML1 3JX, United Kingdom
URL: https://clinicaltrials.gov/show/NCT00502710

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress